UF Health Researcher Finds Potential Treatment for Lost Sense of Smell
UF researcher Jennifer Mulligan is investigating an innovative treatment to restore the lost sense of smell, offering new hope for patients experiencing anosmia.
Dalir’s CHIP Lab Works To Revolutionize Low-Power Components for AI Hardware Accelerators
UF’s CHIP Lab, led by Hamed Dalir received up to $435,000 from the Naval Surface Warfare Center, Crane Division, to develop innovative ADC and DAC solutions for next-generation AI accelerator processors.
UF Engineering Graduate Programs Climb in U.S. News & World Report Rankings
Four departments at UF’s Herbert Wertheim College of Engineering achieved significant gains in the 2025 U.S. News & World Report rankings.
LightPath Technologies Awarded Initial $2.2 Million IR Camera Order for U.S. Navy Shipboard Optics (SPEIR) Program
UF startup LightPath Technologies announced its acquired subsidiary G5 Infrared has been awarded an initial $2.2 million engineering development model (EDM) order for infrared cameras by L3Harris Technologies.
Mission Health Communities Enhances Resident Care Through eBrief™ Early Adopter Program
UF Innovate | Accelerate resident client etectRx™ announces its partnership with Mission Health Communities, marking a significant addition to the growing roster of eBrief™ partners.
UF Geologist To Help Plan Potential NASA Mission
UF researcher Stephen Elardo is playing a vital role in planning a potential mission to the moon’s South Pole-Aitken Basin by helping determine which types and sizes of lunar samples should be collected.
UF Researchers Identify Safer Pathway for Pain Relief
UF researchers have helped identify a novel drug compound that selectively activates pain-altering receptors in the body, offering a potentially safer alternative to conventional pain medications.
Heidari Works to Create Tunable Lasers
UF researchers Elham Heidari, Ph.D., and her team published a paper in ACS Photonics on tunable lasers, earning selection for the Rising Stars in Photonics Virtual Special Issue.
$7.5M Research Project Aims To Improve Safety on Hazardous Tidal Mudflats
A UF researcher is leading a $7.5M, five-year project that examines the geomechanical properties of hazardous tidal mudflats to improve navigation safety.
Rise Therapeutics Reports Ulcerative Colitis Dose Escalation Clinical Results for R-3750 at the Digestive Disease Week (DDW) Conference in San Diego May 3–6
UF startup Rise Therapeutics announced that it will report its first clinical results from the completed dose escalation segment of its R-3750 Phase 1 clinical trial in ulcerative colitis at the upcoming DDW conference.
